Selective Gut Decontamination [6]

Critical Care Medicine

Volumn 31, Issue 11, 2003, Pages 2715-2716

  Schippers, E F ^a   Van Dissel, J T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFUROXIME; ENDOTOXIN; NEOMYCIN; POLYMYXIN; TOBRAMYCIN;

ANTIMICROBIAL ACTIVITY; BACTERIUM CULTURE; CARDIOPULMONARY BYPASS; CYTOKINE RELEASE; DRUG CHOICE; DRUG MECHANISM; ENDOTOXEMIA; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; LETTER; PREOPERATIVE CARE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0344011010     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000092453.44522.FC     Document Type: Letter

References (12)

1. Oudemans-van Straaten HM, van Saene HK, Zandstra DF: Selective decontamination of the digestive tract: Use of the correct antibiotics is crucial. Crit Care Med 2003; 31: 334-335
2. Bouter H, Schippers EF, Luelmo SAC, et al: No effect of preoperative selective gut decontamination on endotoxemia and cytokine activation during cardiopulmonary bypass: A randomized, placebo-controlled study. Crit Care Med 2002; 30:38-43
3. Guiot HF, van Furth R: Selective decontamination in bone marrow transplant recipients. Epidemiol Infect 1992; 109:349-360
4. Guiot HF, van den Broek PJ, van der Meer JW, et al: Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: A double-blind, placebo-controlled study. J Infect Dis 1983; 147:615-623
5. Stoutenbeek CP, van Saene HK: Infection prevention in intensive care by selective decontamination of the digestive tract. J Crit Care 1990; 5:137-156
6. Rogers MJ, Moore R, Cohen J: The relationship between faecal endotoxin and faecal microflora of the C57BL mouse. J Hyg (Lond) 1985; 95:397-402
7. van Langevelde P, Kwappenberg KM, Groeneveld PH, et al: Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: Delay between killing by ceftazidime and imipenem and release of LPS. Antimicrob Agents Chemother 1998; 42:739-743
8. Sjolin J, Goscinski G, Lundholm M, et al: Endotoxin release from Escherichia coli after exposure to tobramycin: Dose-dependency and reduction in cefuroxime-induced endotoxin release. Clin Microbiol Infect 2000; 6:74-81
9. Danner RL, Joiner KA, Rubin M, et al: Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide. Antimicrob Agents Chemother 1989; 33:1428-1434
10. Gough M, Hancock RE, Kelly NM: Antiendotoxin activity of cationic peptide antimicrobial agents. Infect Immun 1996; 64: 4922-4927
11. Goris H, de Boer F, van der Waaij D: Oral administration of antibiotics and intestinal flora associated endotoxin in mice. Scan J Infect Dis 1986; 18:55-63
12. Goris H, Daenen S, Halie MR, et al: Effect of intestinal flora modulation by oral polymyxin treatment on hemopoietic stem cell kinetics in mice. Acta Haematol 1986; 76:44-49